Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$0.71 - $0.97 $1,138 - $1,555
-1,604 Reduced 84.24%
300 $0
Q3 2023

Oct 25, 2023

BUY
$0.96 - $2.01 $1,539 - $3,224
1,604 Added 534.67%
1,904 $1,000
Q4 2022

Jan 24, 2023

SELL
$2.06 - $3.47 $900 - $1,516
-437 Reduced 59.29%
300 $0
Q3 2022

Nov 10, 2022

BUY
$2.6 - $5.12 $1,136 - $2,237
437 Added 145.67%
737 $2,000
Q2 2021

Jul 27, 2021

BUY
$9.87 - $13.32 $2,960 - $3,996
300 New
300 $4,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $795M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.